Our Product Discovery of Linaclotide Linzess® (linaclotide) capsules for oral use Please see full LINZESS Prescribing Information below and a website dedicated to providing you with product-specific information. In order to monitor the safety of our product, we encourage reporting any side effects experienced while taking LINZESS to AbbVie at 1-800-678-1605. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. Click here for full US Prescribing Information including BOXED WARNING. Learn more about Linzess® Clinical Trial Transparency and Data Sharing Ironwood is committed to sharing the results of our clinical development programs. View Now Partnerships Collaboration is a core value and critical to our success Learn More Our Company Our Values Our Executive Team Our Board of Directors Open Payments and Transparency Our Product Discovery of Linaclotide Report a possible side effect Our Pipeline Partnerships Patients Join Us Open Positions Internships, Co-ops and Fellowships Things You Should Know Investors Events & Presentations Corporate Governance Financial Information Stock Information Investor FAQ Press Releases Investor Contacts Media Contact Us Follow Us Privacy Policy Terms of Use California Privacy Policy Site Map Contact Us Copyright © 2021, Ironwood Pharmaceuticals, Inc. All Rights Reserved LINZESS®, CONSTELLA®, IRONWOOD® and their associated logos are trademarks of Ironwood Pharmaceuticals, Inc. Any other trademarks referred to herein are the property of their respective owners. All rights reserved.